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ABSTRACT: Absorption of glucose, via intestinal Na+/glucose cotransporter 1 (SGLT1), activates salt and water absorption
and is an effective route for treating Escherichia coli (E. coli)-induced diarrhea. Activity and expression of SGLT1 is regulated by
sensing of sugars and artificial/natural sweeteners by the intestinal sweet receptor T1R2-T1R3 expressed in enteroendocrine
cells. Diarrhea, caused by the bacterial pathogen E. coli, is the most common post-weaning clinical feature in rabbits, leading to
mortality. We demonstrate here that, in rabbits with experimentally E. coli-induced diarrhea, inclusion of a supplement
containing stevia leaf extract (SL) in the feed decreases cumulative morbidity, improving clinical signs of disease (p < 0.01). We
show that the rabbit intestine expresses T1R2-T1R3. Furthermore, intake of SL enhances activity and expression of SGLT1 and
the intestinal capacity to absorb glucose (1.8-fold increase, p < 0.05). Thus, a natural plant extract sweetener can act as an
effective feed additive for lessening the negative impact of enteric diseases in animals.
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■ INTRODUCTION
Na+/glucose cotransporter 1, SGLT1, is the major route for
absorption of glucose across the intestinal brush border
membrane. Absorption of glucose via SGLT1 activates
electrolyte and water absorption. In humans, this strategy has
been used in oral rehydration therapy, which is the safest and
most effective remedy for treating life-threatening diarrhea
induced by agents such as Vibrio cholerae and Escherichia coli.1,2
The condition is caused by toxic peptides produced by bacteria
stimulating the conversion of guanosine 5′-triphosphate
(GTP) to cyclic guanosine 5′-monophosphate (cGMP) by
the enzyme guanylate cyclase. Increased intracellular cGMP
inhibits intestinal fluid uptake, resulting in net fluid secretion
and thus diarrhea.
The gut epithelium can sense sugars and artificial sweeteners
via the sweet receptor comprising Taste family 1 Receptor 2
(T1R2) and 3 (T1R3) expressed on the luminal membrane of
enteroendocrine cells (EEC).3,4 This results in secretion of gut
hormones, glucagon-like peptide 1 (GLP-1), glucagon-like
peptide 2 (GLP-2), and glucose-dependent insulinotropic
peptide (GIP) from EEC.5,6 GLP-2 upregulates SGLT1
activity and expression7,8 in neighboring absorptive enterocytes
via a neuro-paracrine pathway.6,9 GLP-2 also increases the
villus height and intestinal barrier function,10,11 thereby
promoting gut health. These effects have also been reported
in piglets12 and calves and ruminants.13
The sweet taste receptor is similarly activated by natural,
high-intensity sweeteners, such as stevia,14 leading to increased
expression and activity of SGLT1, providing the capacity for
enhanced glucose (electrolyte and water) absorption.
Rabbits are raised for a variety of commercial reasons. Their
meat, wool, and fur are valuable commodities, as is their
nitrogen-rich manure and high protein milk. They are also very
popular as household pets. Diarrhea is the most common post-
weaning clinical feature in rabbits, leading to significant rates of
mortality. With current trends aimed at decreasing the use of
antibiotics, feed additives that can improve rabbit health and
performance in the face of disease is highly desirable. This is
especially relevant in Europe, where antibiotic use in animal
feed is already banned, and the use of natural alternatives, for
disease prevention, is encouraged. Furthermore, in Europe, the
use of artificial sweeteners, used routinely in farm animal
nutrition,12,13 is prohibited as supplements in rabbit feed. It is
not known if a natural high-intensity sweetener such as stevia
leaf extract (SL), which can be used in rabbit feed, will elicit
similar effects as seen with artificial sweeteners in farm animals,
assisting to prevent and ameliorate enteric diseases in rabbits.
Here, we show that when rabbits are challenged with
colibacillosis, inclusion of a supplement containing SL in rabbit
feed leads to a significant reduction in diarrhea and bloat,
improving the health status. Furthermore, we demonstrate that
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the rabbit intestine expresses the intestinal sweet receptor
T1R2-T1R3 and that inclusion of SL in the feed results in
upregulation of SGLT1 activity and protein and mRNA
abundance in the small intestine. Thus, a better understanding
of the molecular mechanism underlying intestinal nutrient
absorption provides a rational strategy for using a natural feed
additive for alleviating enteric disorders and promoting the
health and well-being of animals.
■ MATERIALS AND METHODS
Chemicals. SL supplement (containing 17.75% stevia leaf extract
and 2% capsicum oleoresin (for concentration see below); Sucram
TakTik) was from Pancosma, Rolle, Switzerland. Zymo Total RNA
isolation kit with on-column DNase 1 digestion was from Cambridge
Bioscience, Cambridge, UK. dT20 primers and superscript III reverse
transcriptase was from Life Technologies, Paisley, UK, and QIAquick
PCR purification kit was from Qiagen, Crawley, West Sussex, UK.
Consensus primers for mammalian T1R2 and T1R3 were purchased
from Eurogentec, Seraing, Belgium. Q5 Hot Start High-Fidelity DNA
Polymerase was purchased from New England Biolabs, Hitchin,
Herts, UK, and pGEM-T Easy vector was from Promega, South-
ampton, UK. SYBR green JumpStart Taq ReadyMix, dithiothreitol,
benzamidine, phenylmethylsulfonyl fluoride, Bio-Max Light Chem-
iluminescence Film, β-actin antibody (clone AC-15), D.P.X. neutral
mounting medium, donkey serum, 10% neutral buffered formalin, and
Mayer’s Hemalum (3.3 mM Mayer’s Hemalum-hematoxylin, 1 mM
sodium iodate, and 0.42 mM potassium alum) were purchased from
Sigma-Aldrich, Poole, Dorset, UK. Bio-Rad protein assay solution and
polyvinylidene difluoride (PVDF) membrane were from Bio-Rad
Laboratories Ltd., Hemel Hempstead, UK. The antibody to SGLT1
was raised in rabbits (custom synthesis) to a recombinant peptide
corresponding to amino acids 554−640 of rabbit SGLT1 protein.
Horseradish peroxidase-linked secondary antibodies were purchased
from DAKO Ltd., Cambridge, UK. Immobilon Western Chemilumi-
nescent HRP Substrate and cellulose acetate/nitrate filter were
purchased from Millipore, Hertfordshire, UK, and [U-14C]-D-glucose
(10.6 GBq/mmol) was from Perkin Elmer, Seer Green, Bucks, UK.
Scintillation fluid (Optiphase HiSafe 3) was purchased from Fisher
Scientific, UK, and Eosin Y solution (1% (w/v) eosin aqueous) was
from HD Supplies, Buckingham, Bucks, UK. Chromogranin A
antibody (ab8204) was from Abcam, Cambridge, UK. Antibodies to
T1R2 (sc-50306) and T1R3 (sc-22458) were from Santa Cruz
Biotechnology, Inc., Heidelberg, Germany, and IgG Cy3- FITC-
conjugated secondary antibodies were from Stratech Scientific,
Newmarket, UK. 4′,6-Diaminido-2-phenylindole (DAPI) was pur-
chased from Vector Laboratories, Peterborough, UK.
Phase 1. Animals, Treatments, and Experimental Conditions.
The animal experiment was conducted at the Talhouet Research
Center (Saint Nolff, France). All animal procedures were approved by
the Ethical Committee for Animal Experimentation of NEOVIA and
by the Ministry of Higher Education of Research and Innovation,
France (experimental reference #03835.03). Animal numbers were
determined based on power calculations conducted using data from
previous experiments performed in the same facility wherein
colibacillosis challenge was used. Thirty-six day-old Souche Hyplus
PS59 rabbits (http://www.hypharm.fr; n = 300) were weaned,
blocked by sex, litter origin, and body weight and assigned to one of
four dietary treatments (n = 75/trt): unsupplemented diet or a diet
supplemented with 50, 75, or 100 ppm SL containing maximum of
3.3, 4.9, and 6.5 μM capsaicin. Animals were housed in cages (five
rabbits per cage) with ad libitum access to feed and water. Rabbit feed
was formulated for a typical fattening ration containing 15.5% crude
protein and a metabolizable energy (ME) of 22.9 kcal/100 g feed. All
feed was free of antibiotics and medications, including coccidiostats.
The room was maintained at 19 °C and illuminated between 0700
and 1700 each day. All animals were monitored daily.
On day 44 of age (day 0 of infection), all rabbits were orally
inoculated with 5 × 106 CFU/mL E. coli O103 LY265 inoculum
(INRA, Nouzilly, France; dose determined in preliminary experiments
and validated in several separate experiments).
Measurements. Feed intake was measured daily per cage by
weighing of refusals. Live weights of individual rabbits were measured
on days −2, 5, 12, 19, and 26 post infection (corresponding to 42, 49,
56, 63, and 70 days of age), and average daily gain (ADG) was
calculated from individual body weights. Feed efficiency (G:F; gain/
feed) was calculated per cage. Morbidities [visual signs of diarrhea
and discoloration of feces, bloat (swollen stomach), sunken eyes, dull
fur, and low energy and mobility] were assessed daily by two
technicians trained by a veterinarian. Morbidities were not quantified
but were simply noted as present or absent based on subjective visual
observation by both technicians. The same technicians performed the
scoring throughout the study to avoid variation due to the observer.
Mortalities were also recorded daily; dead animals were removed from
cages upon detection, and visible clinical signs were noted. At the
peak of mortality during clinical disease, a random selection of rabbits
(n = 10) was necropsied to verify colibacillosis as the cause of death
(via E. coli serotyping of intestinal content).
The experiment ended on day 26 post infection (when animals
were 70 days of age), and all remaining animals were euthanized by a
trained technician. The average body weight at 70 days of age was
multiplied by the number of animals alive to estimate production
weight per treatment.
Statistical Analysis. Data were analyzed by ANOVA using the SAS
Mixed Procedure with a Dunnett’s adjustment for multiple
comparisons and orthogonal contrasts to test for linearity. Treatment
and time were fixed effects, whereas sex and cage were treated as
random effects. Statistical significance was set at p < 0.05.
Phase 2. The experiments in phase 2 were undertaken to
understand the molecular mechanisms underlying the intestinal
response of rabbits to SL.
Animals, Dietary Trial, and Gut Tissue Sampling. The animal
experiment was conducted at the Talhouet Research Center (Saint
Nolff, France). All animal procedures were approved by the Ethical
Committee for Animal Experimentation of NEOVIA and the Ministry
of Higher Education of Research and Innovation, France (exper-
imental reference #03835.03). Animal numbers were determined
using gut responses and variation associated with supplementation
with artificial sweeteners reported in published articles.6,12,13 Forty-
two 60 day-old Souche Hyplus PS59 rabbits (http://www.hypharm.
fr) were blocked by sex and body weight and assigned to one of two
dietary treatments starting on day 61 of age (n = 21 rabbits/
treatment): unsupplemented diet or a diet supplemented with 75 ppm
SL (dose chosen based on responses observed in phase 1). Animals
were housed in cages (five rabbits per cage) with ad libitum access to
feed and water. Rabbit feed was formulated for a typical fattening
ration containing 15.5% crude protein and an ME of 22.9 kcal/100 g
feed. All feed was free of antibiotics and medications, including
coccidiostats. The room was maintained at 19 °C and illuminated
between 0700 and 1700 each day. After the 9 day treatment period
(the period of 9 days was selected to cover the gut epithelial cell
turnover that takes 4−5 days in the majority of species and was
extended to 9 days due to travel delays for the researcher from the UK
traveling to France for harvesting intestinal tissues) at 70 days of age
(same slaughter age as phase 1), all rabbits were weighed and
euthanized by intracardiac injection of Euthasol after sedation starting
at 9 am. Intestinal tissues were removed: duodenal, 10 cm distal to the
pyloric ceca; ileal, 10 cm proximal from the ileocecal valve; and
jejunal, at the midpoint between the pyloric ceca and ileocecal valve.
Tissue samples were collected from 10 rabbits/treatment (blocked by
sex and body weight at slaughter), rinsed in ice-cold saline, and either
placed into cryovials or wrapped in aluminum foil and frozen
immediately in liquid nitrogen or pinned to dental plastic and fixed in
10% neutral buffered formalin at 4 °C. Fixed tissues were transferred
to 20% sucrose in phosphate-buffered saline (PBS) after 24 h and
stored at 4 °C. Frozen tissues were stored at −80 °C before shipping
to the UK on dry ice, whilst fixed samples were shipped to the UK on
wet ice for subsequent analysis.
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Cloning of Rabbit T1R2 and T1R3. Total RNA was isolated from
rabbit intestinal tissues using the Zymo Total RNA isolation kit with
on-column DNase 1 digestion. RNA was quantified by UV
spectrophotometry (assuming an OD260 value of 1 = 40 μg/mL)
and integrity determined by agarose gel electrophoresis. Comple-
mentary DNA (cDNA) was prepared using oligo dT20 primers and
superscript III reverse transcriptase, purified using the QIAquick PCR
purification kit, and quantified by UV spectrophotometry (assuming
an OD260 value of 1 = 33 μg/mL). Consensus primers for mammalian
T1R2 and T1R3 are listed in Table 1. Each PCR reaction mix
contained 0.5 μM of each forward and reverse primer, 0.5 U of Q5
Hot Start High-Fidelity DNA Polymerase, and 25 ng of template
cDNA in a final volume of 25 μL. Polymerase chain reaction (PCR)
cycling was carried out as follows: initial denaturation at 98 °C for 1
min, 25 cycles of denaturation at 98 °C for 10 s, annealing for 10 s,
and extension at 72 °C for 30 s followed by a final extension step at 72
°C for 2 min. PCR amplicons were gel purified using 1% agarose gels,
cloned into the pGEM-T Easy vector, and custom sequenced
(Eurofins-MWG, Ebersberg, Germany). Sequence alignments and
amino acid translations were performed using commercial software
(Vector NTI, Life Technologies).
The radial phylogram shown in Figure 7, depicting the
phylogenetic relationship of rabbit T1R3 to various mammalian
homologs, was constructed by neighbor-joining analysis15 of distance
matrices generated using the PROTDIST program (Jones−Taylor−
Thornton similarity model)16 as part of the phylogenetic inference
package, PHYLIP.17
Quantitative PCR. Relative mRNA expression in the intestine was
determined by quantitative real-time PCR (qPCR). cDNA was
prepared from total RNA as described above and diluted to 5 ng/μL.
Primers to rabbit SGLT1, β-actin (ACTB), RNA polymerase II
(POLR2A), and β-2-microglobulin (B2M) were designed using
Primer-BLAST18 and purchased from Eurogentec (see Table 1). Each
qPCR reaction consisted of 25 ng of cDNA template, 1X SYBR green
JumpStart Taq ReadyMix, and 900 nM of each primer in a total
volume of 25 μL. The PCR cycling consisted of initial denaturation at
95 °C for 2 min followed by 45 cycles of 95 °C for 15 s and 60 °C for
1 min. Assays were performed in triplicate using a RotorGene 3000
(Qiagen) with relative abundance calculated using RG-3000
comparative quantification software (Qiagen). Abundance of
SGLT1 mRNA was normalized to the genomic mean of ACTB,
POLR2A, and B2M housekeeping genes, the expression of which did
not change throughout the study. qPCR assays without the RT step
were routinely employed as negative controls and showed no
amplification. Melt curve analysis showed no primer dimer formation
in the assays. PCR amplicons were cloned into pGEM-T easy vectors
and sequenced to confirm veracity.
Preparation of Brush Border Membrane Vesicles. Brush border
membrane vesicles (BBMV) were isolated from different regions of
rabbit small intestinal tissues based on the procedure described by
Shirazi-Beechey et al.,19 with modifications outlined by Rowell-
Schaf̈er et al.20 and Dyer et al.21 All steps were carried out at 4 °C.
Tissues were thawed in a buffer solution (100 mM mannitol, 2 mM
HEPES/Tris pH 7.1 with protease inhibitors, 0.5 mM dithiothreitol,
0.2 mM benzamidine, and 0.2 mM phenylmethylsulfonyl fluoride),
cut into small pieces, and vibrated for 1.5 min at speed 5 using a
FUNDAMIX vibro-mixer (DrM, Dr. Mueller AG, Maennedorf,
Switzerland) in order to free intestinal epithelial cells. The filtrate
was then homogenized using a Polytron (Ystral, Reading, Berkshire,
UK) for 20 s. Next, MgCl2 was added to a final concentration of 10
mM and the solution stirred on ice for 20 min. The suspension was
then centrifuged for 10 min at 3000g (SS34 rotor, Sorvall, UK), and
the resulting supernatant was spun for 30 min at 30,000g. The pellet
was suspended in buffer (100 mM mannitol, 0.1 mM MgSO4, and 20
mM HEPES/Tris pH 7.1) and homogenized with 10 strokes of a
Potter Elvehjem Teflon hand-held homogenizer before centrifuging
for 30 min at 30,000g. The final pellet was resuspended in an isotonic
buffer solution (300 mM mannitol, 0.1 mM MgSO4, and 20 mM
HEPES/Tris pH 7.4) and homogenized by passing through a 27-
gauge needle several times. The protein concentration in the BBMV
was estimated by its ability to bind Coomassie blue according to the
Bio-Rad assay technique. Porcine γ-globulin was used as the standard.
Inclusion of protease inhibitors in the buffers is essential for avoiding
SGLT1 protein degradation.
In preparation for western blot analysis, aliquots of freshly prepared
BBMV were diluted with the sample buffer (62.5 mM Tris/HCl pH
6.8, 10% (v/v) glycerol, 2% (w/v) SDS, 0.05% (v/v) β-
mercaptoethanol, and 0.05% (w/v) bromophenol blue) and stored
at −20 °C until use. The remaining BBMV were divided into aliquots
and stored in liquid nitrogen or used immediately for glucose uptake
studies.
Western Blotting. The abundance of SGLT1 and β-actin proteins
in the BBMV isolated from rabbit small intestine was determined by
western blotting as described previously.12,21 Protein components of
BBMV (20 μg) were separated by sodium dodecyl sulfate (SDS)-
polyacrylamide gel electrophoresis on 8% (w/v) polyacrylamide mini
gels, containing 0.1% (w/v) SDS, and electrotransferred to
polyvinylidene difluoride (PVDF) membranes. The PVDF mem-
branes were blocked for 1 h at room temperature (RT) in PBS
containing 0.5% (w/v) nonfat dried milk and 0.05% (v/v) Tween-20
(PBS-TM). Incubation for 1 h with the SGLT1 antibody diluted
1:1000 in PBS-TM then followed.
Immunoreactive bands were detected by incubation for 1 h with
affinity purified horseradish peroxidase-linked anti-rabbit secondary
antibody diluted 1:2000 in PBS-TM and visualized using the
Immobilon Western Chemiluminescent HRP Substrate and Bio-
Max Light Chemiluminescence Film. The intensity of the
immunoreactive bands was quantified using scanning densitometry
(Total Lab, Newcastle-upon-Tyne, UK).
The PVDF membranes were stripped by 3 × 10 min washes in 137
mM NaCl and 20 mM glycine/HCl (pH 2.5) and then reprobed with
a monoclonal antibody to β-actin used as a loading control. Blocking
solution consisted of 0.1% (v/v) Triton X-100 and 0.1 mM EDTA in
PBS (PBS-TE) and 5% (w/v) skimmed milk powder. PBS-TE was
Table 1. Primers Used for PCR and qPCR
primer name accession no. sequence Tm (°C)
RbACTB S NM_001101683 5′-CCTTCTACAACGAGCTGCGAG-3′ 51.4
RbACTB AS NM_001101683 5′-GCCCTCGTAGATGGGTACTG-3′ 49.9
RbPOLR2A S XM_017348893.1 5′-ACGCTGCTCTTCAACATCCA-3′ 60
RbPOLR2A AS XM_017348893.1 5′-CCAGCGTAGTGGAAGGTGTT-3′ 60
RbB2M S XM_008269078.2 CTAGTCTTGTTCCCCTGCCT 58.9
RbB2M AS XM_008269078.2 ATCAATCTGGGGCGGATGAAA 60
RbT1R2 S XM_017346518 5′-TCTGGAACGTCAGCTTCACC-3′ 52.5
RbT1R2 AS XM_017346518 5′-GTGCTTCAGCATGGGGTAGT-3′ 51.6
RbT1R3 S 5′-GCAAGTTCTTCAGCTTCTTCCT-3′ 51.5
RbT1R3 AS 5′-TACATGTTCTCCAGGAGCTGC-3′ 51.9
RbSGLT1 S NM_001101692 5′-TGTCAAGGCTGGCTGTATCC-3′ 51.4
RbSGLT1 AS NM_001101692 5′-CTCCTCTGGTTCCACGCAA-3′ 51.3
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used for the incubation and washing buffers. Horseradish peroxidase-
linked anti-mouse secondary antibody diluted 1:2000 in PBS-TE was
used and visualized as above.
Measurement of Na+-Dependent Glucose Uptake. Na+-depend-
ent glucose uptake into rabbit intestinal BBMV was measured as
described.12,19 The uptake of D-glucose was initiated by the addition
of 100 μL of incubation medium (100 mM NaSCN (or KSCN), 100
mM mannitol, 20 mM HEPES/Tris (pH 7.4), 0.1 mM MgSO4, 0.02%
(w/v) NaN3, and 0.1 mM [U-
14C]-D-glucose (10.6 GBq/mmol)) to
BBMV (100 μg of protein) at 37 °C. The reaction was stopped after 3
s by the addition of 1 mL of ice-cold stop buffer (150 mM KCl, 20
mM HEPES/Tris (pH 7.4), 0.1 mM MgSO4, 0.02% (w/v) NaN3, and
0.1 mM phlorizin). Aliquots (0.9 mL) of the reaction mixture were
removed and filtered under vacuum through a 0.22 μm pore cellulose
acetate/nitrate filter. The filter was washed with 5 × 1 mL of ice-cold
stop buffer and placed in a vial containing 4 mL of scintillation fluid,
and the radioactivity retained on the filter measured using a Tri-Carb
2910TR Liquid Scintillation Analyzer (PerkinElmer, Bucks, UK). All
uptakes were measured in duplicate.
Morphometry. Rabbit small intestinal tissues were fixed and cryo-
protected before being embedded in OCT (Fisher Scientific, UK),
frozen at −20 °C, and then kept at −80 °C until use. Tissue blocks
were sectioned (10 μm) on a cryostat (Leica, CM 1900UV-1-1,
Milton Keynes, Buckinghamshire, UK) and thaw-mounted onto
polylysine-coated slides. Morphometric analysis was performed as
described previously.12 The sections were exposed to tap water for 1
min, transferred to Mayer’s Hemalum for 1 min, and washed gently
with running tap water for 5 min. They were stained with eosin Y
solution for 30 s and subsequently dehydrated by stepwise washing in
70% ethanol (v/v) for 2 × 1 min, absolute ethanol for 2 × 1 min, and
xylene for 3 × 1 min before mounting with the D.P.X. neutral
mounting medium.
Digital images were captured with an Eclipse E400 microscope and
DXM 1200 digital camera (Nikon, Kingston upon Thames, Surrey,
UK), analyzed using ImageJ software (Wayne Rasband, US National
Institutes of Health, Bethesda, MD), and calibrated using a 100 μm
gradient slide. The crypt depth and the villus height were measured as
the average distance from the crypt base to crypt-villus junction and
villus base to villus tip, respectively. The villus height and the crypt
depth measurements were taken from an average of 16 well-oriented
crypt-villus units. A minimum of three images were captured per
section with a minimum of eight sections prepared per animal, with
each section being five sections apart within the block. All images
were captured under the same conditions with care taken to ensure
that the same villus was not counted twice.
Immunohistochemistry. Immunohistochemistry was performed as
previously described.22 Tissue sections (10 μm thick, on polylysine
coated slides) were washed five times for 5 min each in PBS. Slides
were then incubated for 1 h in a blocking solution (10% (v/v) donkey
serum in PBS) at room temperature in a humidified chamber.
Subsequently, sections were incubated overnight at 4 °C with primary
polyclonal antibodies. The antibodies to chromogranin A (1:100),
T1R2 (1:200), and T1R3 (1:200) were used. The T1R2 antibody was
raised against a peptide corresponding to residues 426−570 of mouse
T1R2 that shares 66% homology with rabbit T1R2 and T1R3 to a
peptide corresponding to the C-terminus of human T1R3. Cloned
rabbit T1R3 shares 69% homology to human T1R3. After incubation
of sections with primary antibodies, slides were washed five times for
5 min each in PBS and subsequently stained for 1 h at room
temperature using a 1:500 dilution of Cyanine 3 (Cy3)- or fluorescein
isothiocyanate (FITC)-conjugated anti-goat, anti-rabbit, and anti-
mouse IgG secondary antibodies. The composition of the buffer
containing antibodies (primary or secondary) was 2.5% (v/v) donkey
serum, 0.25% (w/v) NaN3, and 0.2% (v/v) Triton X-100 in PBS.
Finally, slides were washed five times for 5 min each in PBS and then
mounted with the Vectashield Hard Set Mounting Medium with
(DAPI). Immunofluorescent labeling of chromogranin A, T1R2, and
T1R3 proteins was visualized using an epifluorescence microscope
(Nikon, Kingston-Upon-Thames, UK), and images were captured
with a digital camera (model C4742-96-12G04, Hamamatsu
Photonics, Welwyn Garden City, UK). Omission of primary
antibodies was routinely used as the control.
Statistical Analysis. All parameters were tested for normality by
the Shapiro−Wilk test. For comparison of SGLT1 expression in
intestinal tissues and measurements of crypt-depth/villus height in
intestinal tissues a Student’s two-tailed t-test was used to determine
the statistical significance (GraphPad Prism 5, GraphPad Software
Inc., La Jolla, CA). The level of statistical significance was set at p <
0.05.
■ RESULTS
Phase 1 Studies. Assessment of Rabbit Performance.
Rabbit daily weight gain, feed intake, and gain to feed ratios are
presented in Figure 1. E. coli inoculation markedly decreased
daily weight gain (p < 0.001; Figure 1A) across all dietary
treatments until surviving animals had recovered by day 19
post infection (63 days of age). There was no effect of dietary
supplementation on daily weight gain (p > 0.70; Figure 1A).
Feed intake was not affected by inoculation (Figure 1B). There
Figure 1. Growth performance of rabbits supplemented with 0, 50,
75, or 100 ppm of an additive containing natural high-intensity
sweetener (SL) and inoculated with Escherichia coli on day 44 of age
(red arrow). Data presented are (least-squares) (LS) Means, with
pooled SEM per group indicated by error bars. (A) Daily weight gain.
(B) Daily feed intake. (C) Gain:feed.
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was a trend for an effect of dietary treatment (p < 0.10) such
that the animals supplemented with 75 ppm SL consumed
more feed in the middle of the clinical phase of disease (day 12
post infection; 56 days of age; Figure 1B). Inoculation
markedly decreased efficiency of growth (p < 0.001; Figure
1C), and this was not influenced by dietary treatment (p >
0.50). None of the groups recovered to pre-inoculation feed
efficiency for the duration of the study.
Mortality and Morbidities. Rabbit rates of mortality are
presented in Figure 2. The colibacillosis challenge had a strong
effect and elicited a marked increase in mortality rate with peak
levels reached on day 19 post infection (63 days of age). There
was no effect of dietary treatment on the percent rate of
mortality (p > 0.30), and cumulative death was increased by
inoculation (p < 0.001; Figure 2). The average body weight on
day 26 post infection (70 day of age) was multiplied by the
number of animals alive on that day to give production weights
of 112.5, 119.2, 121.2, and 111.9 g for animals supplemented
with 0, 50, 75, and 100 ppm SL, respectively.
Morbidities (diarrhea and bloat) are presented in Figure 3.
The majority of morbidities observed were diarrhea, and this
was increased with inoculation (p < 0.001; Figure 3A). All
animals reached pre-inoculation levels by day 26 post infection
(70 d of age), and there was no effect of dietary treatment on
percent morbidities (p > 0.40; Figure 3A). The cumulative
number of morbidities also increased with inoculation (p <
0.001; Figure 3B), and there was a significant treatment effect
characterized by fewer morbid animals in the 50 and 75 ppm
SL groups compared to control animals (p < 0.01; Figure 3B).
Phase 2 Studies. Rabbit SGLT1 Expression and Activity
Are Enhanced by Feed Supplementation with the Natural
High-Intensity Sweetener, Stevia Leaf. SGLT1 expression and
activity were determined along the length of the small intestine
in rabbits fed a diet supplemented with SL and the same diet
without SL (control diet). Irrespective of diets, levels of
SGLT1 mRNA, protein, and function were highest in the
duodenum (duodenum > jejunum > ileum). There was a 1.4-
fold (p < 0.05) and 1.3-fold (p < 0.001) increase in SGLT1
mRNA abundance in the duodenum and jejunum of rabbits
fed a diet supplemented with SL compared to control diet
(Figure 4A). SGLT1 protein abundance measured in BBMV
increased by 1.6-fold (p < 0.001) and 1.6-fold (p < 0.001) in
the duodenum and jejunum of rabbits fed a diet supplemented
with SL compared to control (Figure 4B). This was matched
by a 1.8-fold (p < 0.050) and 1.7-fold (p < 0.050) increase in
the initial rates of D-glucose transport into BBMV in the
duodenum and jejunum of rabbits fed the diet supplemented
with SL (Figure 4C). No increases in either SGLT1 mRNA,
protein abundance, or the initial rate of D-glucose transport
into BBMV were observed in the ileum of rabbits fed the diet
supplemented with SL compared to control diet (Figure 4).
There was a 1.4-fold (p < 0.0010) and 1.3-fold (p < 0.0010)
increase in villus height in the duodenum and jejunum of SL
fed rabbits compared to controls (Figure 5). There was no
difference in the average villus heights of control and SL fed
rabbits in the ileum.
Expression of T1R2 and T1R3 in the Rabbit Intestine. For
rabbit T1R2, PCR primers were designed against the predicted
mRNA sequence available on the National Center for
Biotechnology Information (NCBI) nonredundant nucleotide
database. PCR amplicons using rabbit jejunal cDNA and the
designed T1R2 primers resulted in a 152 bp amplicon, which
was found to be a 100% match to the predicted NCBI
sequence, revealing that the rabbit intestine expresses T1R2
(Figure 6). An alignment of the full-length rabbit T1R2 mRNA
sequence showed 55.3% homology with cow, pig, human,
mouse, and rat T1R2.
As no sequence information on rabbit T1R3 was available
from the current release of the rabbit genome (NCBI
OryCun2.0 Annotation Release 102), it was necessary to
clone rabbit T1R3 to obtain mRNA sequence data and verify
its expression in the rabbit intestine. PCR amplification using
rabbit jejunal cDNA and consensus mammalian T1R3 primers
Figure 2. Mortality of rabbits supplemented with 0, 50, 75, or 100
ppm of an additive containing natural high-intensity sweetener (SL)
and inoculated with Escherichia coli on day 44 of age (red arrow).
Data presented are LS Means, with pooled SEM per group indicated
by error bars. Results show the total number of dead animals over
time. Mortality was calculated by dividing the number of new deaths
recorded at each time point by the number of animals alive at the
previous time point and then multiplying by 100.
Figure 3. Morbidity (diarrhea, abnormal feces, and/or bloat) of
rabbits supplemented with 0, 50, 75, or 100 ppm of an additive
containing natural high-intensity sweetener (SL) and inoculated with
Escherichia coli on day 44 of age (red arrow). Data presented are LS
Means, with pooled SEM per group indicated by error bars. (A)
Percent morbidity over time. (B) Cumulative morbidity over time. *
= p < 0.05; ** = p < 0.01
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Figure 4. Expression and activity of SGLT1 in the intestine of control rabbits and in rabbits maintained on the same diet supplemented with SL.
Brush border membrane vesicles (BBMV) and RNA were isolated from small intestinal tissues of rabbits fed either a control diet (C) or a diet
supplemented with an additive containing natural high-intensity sweetener (SL). (A) Level of SGLT1 mRNA abundance normalized to β-actin,
RNA polymerase II, and β-2-microglobulin mRNA. (B) Expression of SGLT1 and β-actin proteins in BBMV isolated from the small intestine
assessed by western blotting (left panel). Densitometric analysis of SGLT1 protein abundance normalized to β-actin (right panel). (C) Initial rates
of Na+-dependent [U14C]-D-glucose uptake into BBMV. Data were generated in triplicate. Results are shown as mean ± SEM; n = 7 animals.
Statistically significant results determined using a Student’s two-tailed t-test where * = p < 0.050; ** = p < 0.010; *** = p < 0.001.
Figure 5.Morphometric analysis of the rabbit intestine. (A) Representative light micrographs of small intestinal tissues of control and natural high-
intensity sweetener (SL) fed rabbits. Images were obtained at 4× magnification. (B) Morphometric analyses of villus height and crypt depths are
shown as histograms, in (μm) ± SEM. Control (box), SL-fed (solid box); n = 5 animals. Statistically significant results were determined using
Student’s two-tailed t-test where ** = p < 0.010.
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resulted in a 1221 bp fragment that was screened against the
National Center for Biotechnology Information (NCBI)
nonredundant nucleotide database via BlastN,23 identifying
the amplified sequence as being homologous to T1R3 in many
other mammalian species. The mRNA fragment was
subsequently translated to produce a sequence of 407 amino
acids (corresponding to residues 116−515 of human T1R3).
Phylogenetic analysis was performed to construct a radial
phylogram depicting the relationship of rabbit T1R3 to
homologs in various other mammalian species for which
sequence information was available (Figure 7). The NCBI
accession number for the mRNA sequence of rabbit T1R3 is
MK182098.
Immunofluorescence detection for the sweet receptor
subunits, T1R2 and T1R3, and the classical marker for
enteroendocrine cells, chromogranin A, was performed on
frozen tissue sections of rabbit duodenum and jejunum. As
shown in Figure 8, T1R2 and T1R3 were co-expressed in the
same cell (Figure 8A). Furthermore, both T1R2 and T1R3
were co-expressed with chromogranin A, confirming receptor
subunits expression in the enteroendocrine cell (Figure 8B).
■ DISCUSSION
Feeding of low-level antibiotics has been a routine procedure
for controlling enteric pathogens, preventing disease and
improving health and growth, in particular in post-weaning
animals.24 However, increasing antibiotic resistance and rising
consumer concern over prophylactic antibiotic use in animal
production has led to a concerted search for effective
alternatives. In humans, oral rehydration therapy, which relies
on absorption of glucose via SGLT1, activating electrolyte and
water absorption, is a safe and effective method for the
treatment of E. coli- and Vibrio cholerae-induced diarrhea.1 The
discovery that sensing of sugars and sweeteners by the gut-
expressed sweet receptor T1R2-T1R3 enhances the expression
and activity of SGLT14 has allowed the design of novel
strategies for animal nutrition that use artificial sweeteners to
combat diarrheal and enteric diseases.25
E. coli-induced diarrhea is endemic in rabbits and results in
high rates of morbidity and mortality. In the EU, artificial
sweeteners are not permitted to be used in rabbit feed.
We hypothesized that the rabbit intestine expresses the
intestinal sweet receptor T1R2-T1R3 and that a natural high
intensity sweetener (stevia) activates the receptor leading to
SGLT1 upregulation, improving E. coli-induced enteric
disorders. The supplement used in this study contained a
small amount (2%) of capsicum oleoresin (4.9 μM capsaicin)
shown to influence immunity. However, using heterologous
expression of rabbit T1R2-T1R3, we have determined that
capsaicin does not activate rabbit T1R2-T1R3. In contrast,
stevia leaf extract (SL) activates the receptor in a dose-
dependent manner (unpublished data).
Figure 6. Alignment of rabbit T1R2 mRNA sequence with the
corresponding region of cow, pig, human, mouse, and rat T1R2
(numbers in parentheses relate to initiating nucleotide).
Figure 7. Radial phylogram, derived from amino acid sequences,
depicting the phylogenetic relationship of rabbit T1R3 to various
mammalian homologs. The scale bar represents the number of
substitutions per amino acid position.
Figure 8. Co-expression of T1R2 and T1R3 in rabbit small intestine.
(A) Representative image showing expression of T1R2 (green), T1R3
(red), and merged image (yellow) in serial sections of rabbit small
intestine as determined by double immunohistochemistry. (B)
Typical image showing expression of T1R2 or T1R3 (green), the
enteroendocrine marker, chromogranin A (ChA, red), and merged
image (yellow). Specificity of primary antibodies for T1R2 and T1R3
has been validated in mice.6 Omission of primary antibodies for T1R2
or T1R3 showed no nonspecific immunoreactivity with secondary
antibodies (-T1R2 control and -T1R3 control). All images were taken
under 400× magnification; scale bars represent 20 μm.
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Works in the laboratory of Tavakkolizadeh and col-
leagues26,27 have questioned the role of vagal afferent fibers
in SGLT1 regulation by vagotomy and deafferentation with 1
mg of capsaicin applied per animal. They have concluded that
vagal deafferentation abolishes SGLT1 upregulation in
response to increased luminal glucose. They have further
proposed that the specific involvement of vagal afferent fibers
and the enteric nervous system in glucose-sensing initiated
regulatory pathway controlling SGLT1 expression remains
unclear.27
Bates et al.28 have shown that guinea pigs treated with
vehicle and thus having intact vagal afferent fibers were able to
increase the ability to enhance intestinal glucose transport
when switched from a low- to a high-carbohydrate containing
diet. In contrast, animals that orally received a 32.8 mM
solution of capsaicin demonstrated no adaptation to alterations
in dietary composition.28 Interestingly, Nassar et al.29 have
shown that capsaicin (160 and 800 μM) reduces intestinal
alanine absorption when perfused either intraluminally or
applied topically to the vagus nerve, concluding the
involvement of vagal capsaicin sensitive primary afferent fibers
in this inhibitory mechanism.29 Thus, it appears that capsaicin
may have a generalized effect on inhibiting a range of intestinal
nutrient absorptive processes.
The results of studies carried out by Stearns et al.26,27 and
Bates et al.28 are in contrast to this study. In our study, rabbits
fed diets that included stevia and capsaicin (maximum
capsaicin concentration, 4.9 μM) were able to upregulate
glucose transporter expression/activity compared to those fed
the same diet without stevia and capsaicin.
We have shown recently that electric field stimulation of an
isolated segment of the intestine results in a 2- to 3-fold
increase in SGLT1 upregulation.6 This increase is abolished in
the presence of the nerve blocking agent tetrodotoxin,
indicating the involvement of the enteric nervous system in
the regulatory pathway. We used this strategy because sensing
of glucose or artificial sweeteners via T1R2-T1R3, expressed in
enteroendocrine cells, stimulates GLP-2 release, and GLP-2 via
binding to its receptor (GLP-2R) present in enteric neurons
induces an action potential.30 We showed that electric field
stimulation of enteric neurons induces a neural response
leading to secretion of specific neuropeptides that upregulate
SGLT1 expression in the neighboring absorptive enterocyte by
enhancing the half-life of SGLT1 mRNA and thus increased
SGLT1 protein abundance.6 Our studies strongly support the
involvement of enteric neurons in a glucose-sensing initiated
pathway regulating SGLT1 expression.6 Additional studies are
required to address if there is a specific involvement of the
vagus nerve in the SGLT1 regulatory pathway.
In this study, we determined the effect of supplementation of
feed with an additive containing SL on rabbit intestinal SGLT1
expression as sweeteners are known to enhance Na+-dependent
glucose absorption in other mammalian species.4,12,13 Since the
regulatory pathway controlling SGLT1 expression/function is
initiated by activation of the gut-expressed sweet receptor
T1R2-T1R3, we aimed to identify if these receptor subunits
were expressed in the rabbit intestine. The gene for rabbit
T1R2 has previously been identified from the rabbit genome
sequence located on chromosome 13 (NCBI OryCun2.0
Annotation Release 102); however, no information was
available for rabbit T1R3. To determine the expression of
T1R2 and T1R3 in the rabbit intestine, a PCR-based strategy
was used to demonstrate that the rabbit intestine does indeed
express both receptor subunits T1R2 and T1R3 at the mRNA
level. Moreover, by immunohistochemistry, we showed that
T1R2 and T1R3 proteins are co-expressed in the same
intestinal enteroendocrine cell. Furthermore, SGLT1 mRNA,
protein abundance, and glucose transport function were
increased ∼2-fold by dietary inclusion of SL, providing a
higher capacity for the rabbit intestine to absorb glucose,
electrolyte, and water. There was also a 1.4-fold increase in
villus height in rabbits consuming SL likely due to GLP-2
action.13 In these dietary studies, we maintained rabbits on diet
with and without SL for 9 days. We have shown SGLT1
upregulation, with a similar increase in magnitude after 1 or 5
days in response to increased dietary carbohydrates or
sweeteners,4,6 indicating that an increase in SGLT1 expression
occurs in existing absorptive enterocytes.6,7 However, since this
was the first time that we were assessing potential SGLT1
upregulation in response to inclusion of a natural sweetener in
the feed of rabbits, we selected a 5 day dietary trial in order to
cover intestinal epithelial cell turnover that takes 4−5 days in
the majority of species. This period was extended to 9 days
because of the researcher travel delays from the UK to France
for harvesting rabbit intestinal tissues.
We also assessed the effect of supplementation of rabbit feed
with SL on relieving E. coli-induced enteric disorders and
observed that inclusion of SL in the feed decreases morbidity
associated with disease. Although we did not observe a linear
dose response, there was a clear trend for improved
morbidities at the two lower doses. Such hormetic responses
to plant-based supplements are common; very low doses are
beneficial, whereas higher doses are nonspecific and
detrimental.31 To our knowledge, this is the first report
evaluating the effect of a natural sweetener on rabbit health and
performance and the associated molecular mechanisms.
The E. coli challenge elicited a marked impact on
performance characterized by blunted feed intake, decreased
daily gain, and efficiency of growth. These are classical signs of
infection that not only lead to stressed animals but also have a
devastating economic impact in rabbit production. The use of
artificial sweeteners to prevent decreased performance during
stress has been explored previously. For example, Sterk et al.32
reported that supplementation of weanling piglets with
artificial sweeteners prevented the decrease in feed intake
around weaning. Similar observations have been made for
receiving feedlot cattle with respect to both feed intake33 and
daily weight gain.34 Whilst, in this study, the inclusion of SL in
the feed had some impact on feed intake, the major effect was
at the gut level where activation of gut-expressed T1R2-T1R3
by sweeteners results in the secretion of GLP-2, a gut hormone
that can alter appetite,35 and also an increase the intestinal
uptake of glucose leading to improved efficiency of growth.6 It
has indeed been shown that artificial sweeteners directly
introduced into the lumen of the intestine, bypassing the oral
cavity, lead to an increase in expression of SGLT1 and higher
rates of intestinal glucose absorption.27
It was noteworthy that the E. coli challenge in this study was
quite severe, with the mortality rate peaking at nearly 60%
during the clinical trials in some groups. Despite the severity of
the disease challenge, the supplement, at lower doses, showed a
trend for a positive effect on cumulative morbidities. This
observation was consistent with those we made during our
preliminary experiments to establish the optimal timing and
dose of inoculation (data not shown). A previous work using
an artificial high-intensity sweetener has revealed similar effects
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during enteric disease challenge,36 but this is the first report on
the impact of a natural high-intensity sweetener for prevention
of clinical signs of enteritis in rabbits. The positive impact of
the supplement on morbidities, combined with the molecular
responses we observed, are consistent with an increase in GLP-
2 secretion, which is known to be essential for gut repair after
injury,25 and also an enhancement in nutrient absorption.6 In
this scenario, the increased glucose, electrolyte, and water
absorption at the intestinal level likely decreased the clinical
signs of disease associated with diarrhea, and the enteric
lesions caused by the pathogen were likely reduced or repaired
in supplemented animals due to the GLP-2 effect.
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